Literature DB >> 31285287

COPD beyond proximal bronchial obstruction: phenotyping and related tools at the bedside.

Thibaut Capron1, Arnaud Bourdin2, Thierry Perez3, Pascal Chanez4,5.   

Abstract

Chronic obstructive pulmonary disease (COPD) is characterised by nonreversible proximal bronchial obstruction leading to major respiratory disability. However, patient phenotypes better capture the heterogeneously reported complaints and symptoms of COPD. Recent studies provided evidence that classical bronchial obstruction does not properly reflect respiratory disability, and symptoms now form the new paradigm for assessment of disease severity and guidance of therapeutic strategies. The aim of this review was to explore pathways addressing COPD pathogenesis beyond proximal bronchial obstruction and to highlight innovative and promising tools for phenotyping and bedside assessment. Distal small airways imaging allows quantitative characterisation of emphysema and functional air trapping. Micro-computed tomography and parametric response mapping suggest small airways disease precedes emphysema destruction. Small airways can be assessed functionally using nitrogen washout, probing ventilation at conductive or acinar levels, and forced oscillation technique. These tests may better correlate with respiratory symptoms and may well capture bronchodilation effects beyond proximal obstruction.Knowledge of inflammation-based processes has not provided well-identified targets so far, and eosinophils probably play a minor role. Adaptative immunity or specific small airways secretory protein may provide new therapeutic targets. Pulmonary vasculature is involved in emphysema through capillary loss, microvascular lesions or hypoxia-induced remodelling, thereby impacting respiratory disability.
Copyright ©ERS 2019.

Entities:  

Year:  2019        PMID: 31285287     DOI: 10.1183/16000617.0010-2019

Source DB:  PubMed          Journal:  Eur Respir Rev        ISSN: 0905-9180


  5 in total

1.  WNT Signalling in Lung Physiology and Pathology.

Authors:  Yan Hu; Chiara Ciminieri; Qianjiang Hu; Mareike Lehmann; Melanie Königshoff; Reinoud Gosens
Journal:  Handb Exp Pharmacol       Date:  2021

Review 2.  Molecular Characteristics and Treatment of Endothelial Dysfunction in Patients with COPD: A Review Article.

Authors:  Botond Szucs; Csilla Szucs; Mate Petrekanits; Janos T Varga
Journal:  Int J Mol Sci       Date:  2019-09-04       Impact factor: 5.923

Review 3.  Targeted therapy in eosinophilic chronic obstructive pulmonary disease.

Authors:  Mathieu Fieldes; Chloé Bourguignon; Said Assou; Amel Nasri; Aurélie Fort; Isabelle Vachier; John De Vos; Engi Ahmed; Arnaud Bourdin
Journal:  ERJ Open Res       Date:  2021-04-12

Review 4.  Potential Natural Small Molecular Compounds for the Treatment of Chronic Obstructive Pulmonary Disease: An Overview.

Authors:  Liu-Ying Li; Chuan-Tao Zhang; Feng-Ya Zhu; Gang Zheng; Yu-Fei Liu; Ke Liu; Chen-Hui Zhang; Hong Zhang
Journal:  Front Pharmacol       Date:  2022-03-24       Impact factor: 5.810

5.  Adipose triglyceride lipase-mediated lipid catabolism is essential for bronchiolar regeneration.

Authors:  Manu Manjunath Kanti; Isabelle Striessnig-Bina; Beatrix Irene Wieser; Silvia Schauer; Gerd Leitinger; Thomas O Eichmann; Martina Schweiger; Margit Winkler; Elke Winter; Andrea Lana; Iris Kufferath; Leigh Matthew Marsh; Grazyna Kwapiszewska; Rudolf Zechner; Gerald Hoefler; Paul Willibald Vesely
Journal:  JCI Insight       Date:  2022-05-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.